Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-26T04:44:26.414Z Has data issue: false hasContentIssue false
  • English
  • Français

Genetic Screening and Disability Insurance: What Can We Learn from the Health Insurance Experience?

Published online by Cambridge University Press:  01 January 2021

Nancy Kass  and
Amy Medley
Get access Rights & Permissions [Opens in a new window]

Extract

The Human Genome Project has allowed researchers to gain new insights into the genetic causes of health and disease. With this knowledge comes the potential to develop new genetic tests that are capable of predicting the risk of disease or disability among presently healthy individuals. This information is potentially beneficial in that it may allow individuals to develop strategies to reduce their risk of illness and may allow health providers to recognize and treat the early stages of disease more effectively. As knowledge about genetic contributions to disease continues to grow and genetic testing technology becomes more widespread, there is a risk that personal genetic information could be used in ways potentially concerning to consumers. Genetic testing technology could potentially be used to discriminate against individuals in terms of their ability to obtain health, life, and disability insurance. Decreased access to insurance, in turn, significantly hinders access to health care and income for oneself and/or for one's dependent(s).

Type
Special Supplement
Information
Journal of Law, Medicine & Ethics , Volume 35 , Issue S2 , Summer 2007 , pp. 66 - 73
Copyright
Copyright © American Society of Law, Medicine and Ethics 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Kass, N., “Insurance for the Insurers: The Use of Genetic Tests,” Hastings Center Report 22, no. 6 (1992): 6–11.Google Scholar
The first three sections of this paper are based extensively on a previous work by the author entitled, “Insurance for the Insurers: The Use of Genetic Tests.” See id.Google Scholar
Anderson, O., The Uneasy Equilibrium: Private and Public Financing of Health Services in the United States, 1875–1965 (New Haven: Yale University Press, 1968).Google Scholar
Murray, T., “Genetics and the Moral Mission of Health Insurance,” Hastings Center Report 22, no. 6 (1992): 12–17.CrossRefGoogle Scholar
Id.Google Scholar
See Kass, , supra note 1.Google Scholar
Id.Google Scholar
Clifford, K. A. and Iuculano, R. P., “AIDS and Insurance: The Rationale for AIDS-Related Testing,” Harvard Law Review 100 (1987): 1808.CrossRefGoogle Scholar
Musco, T. and Wildsmith, T., Individual Health Insurance: Access and Affordability (Washington, D.C.: Health Insurance Association of America, October 2002).Google Scholar
Employee Benefit Research Institute, Employment-Based Health Care Benefits and Self-Funded Employment-Based Plans: An Overview (Washington, D.C.: Employee Benefit Research Institute, April 2000).Google Scholar
Id.Google Scholar
Pollitz, K., Sorian, R. and Thomas, K., How Accessible Is Individual Health Insurance for Consumers in Less Than Perfect Health? (Washington D.C.: Henry J. Kaiser Family Foundation, June 2001).Google Scholar
Id.Google Scholar
Id.Google Scholar
See Kass, , supra note 1.Google Scholar
Id.Google Scholar
Id.Google Scholar
The Ad Hoc Committee on Genetic Testing/Insurance Issues, “Background Statement: Genetic Testing and Insurance,” American Journal of Human Genetics 56 (1995): 327–331.Google Scholar
See Kass, , supra note 1.Google Scholar
Id.Google Scholar
The Kaiser Family Foundation and the Health Research Educational Trust, Survey of Employer-Sponsored Health Benefits, 2002 Annual Survey, available at <http://www.kaisernetwork.org/health_cast/uploaded_files/ACF4D93.pdf> (last visited March 19, 2007).+(last+visited+March+19,+2007).>Google Scholar
See Employment Benefit Research Institute, supra note 10; Kaiser Family Foundation, supra note 21.Google Scholar
See Kaiser Family Foundation, supra note 21.Google Scholar
See the Ad Hoc Committee on Genetic Testing/Insurance Issues, supra note 18; American Academy of Actuaries, Genetic Information and Medical Expense Insurance, June 2000.Google Scholar
NIH/DOE Working Group on Ethical, Legal, and Social Implications of Human Genome Research, “Genetic Information and Health Insurance,” Human Gene Therapy 4 (1993): 789–808 [hereinafter cited as NIH/DOE Working Group].Google Scholar
See the Ad Hoc Committee on Genetic Testing/Insurance Issues, supra note 18.Google Scholar
Id.Google Scholar
Id.Google Scholar
See NIH/DOE Working Group, supra note 25.Google Scholar
Hudson, K. et al., “Genetic Discrimination and Health Insurance: An Urgent Need for Reform,” Science 270 (1995): 391–393.CrossRefGoogle Scholar
Id.Google Scholar
See Kass, , supra note 1.Google Scholar
Ostrer, H. et al., “Insurance and Genetic Testing: Where Are We Now?” American Journal of Human Genetics 52 (1993): 565–577.Google Scholar
Rothenberg, K. et al., “Genetic Information and the Workplace: Legislative Approaches and Policy Challenges,” Science 275 (1997): 1755–1757.CrossRefGoogle Scholar
See NIH/DOE Working Group, supra note 25.Google Scholar
Id.Google Scholar
See Ostrer, et al., supra note 33.Google Scholar
Gostin, L., Hodge, J. and Calvo, C., Genetics, Policy, and Law: A Report for Policymakers (Washington, D.C.: National Conference of State Legislatures, September 2001).Google Scholar
Id.Google Scholar
See Rothenberg, et al., supra note 34.Google Scholar
Id.Google Scholar
Plaza, C., The Health Insurance Portability and Accountability Act of 1996 (Washington, D.C.: National Conference of State Legislatures, September 2001).Google Scholar
Andrews, L., Future Perfect: Confronting Decisions about Genetics (New York: Columbia University Press, 2001): 5–7; Roche, P. A. and Annas, G. J., “Protecting Genetic Privacy,” Nature Reviews Genetics 2 (2001): 392–396; Watson, M. and Greene, C., “Points to Consider in Preventing Unfair Discrimination Based on Genetic Disease Risk: A Position Statement of the American College of Medical Genetics,” Genetics in Medicine 3 (2001): 436; Geller, G. et al., “Genetic Testing for Susceptibility to Adult-Onset Cancer: The Process and Content of Informed Consent,” JAMA 277 (1997): 1467–1474.CrossRefGoogle Scholar
See the Ad Hoc Committee on Genetic Testing/Insurance Issues, supra note 18.Google Scholar
See Roche, and Annas, , supra note 43.Google Scholar
Green, M. and Botkin, J., “‘Genetic Exceptionalism’ in Medicine: Clarifying the Differences between Genetic and Nongenetic Tests,” Annals of Internal Medicine 138 (2003): 571–575.CrossRefGoogle Scholar
See Gostin, , Hodge, and Calvo, , supra note 38.Google Scholar
See Kass, , supra note 1.Google Scholar
See Gostin, , Hodge, and Calvo, , supra note 38.Google Scholar
See Murray, , supra note 4.Google Scholar
See Kass, , supra note 1.Google Scholar
National Center for Health Statistics, Health Insurance Coverage in the United States, available at <http://www.cdc.gov/nchs/fastats/hinsure.htm> (last visited March 19, 2007).+(last+visited+March+19,+2007).>Google Scholar
Bank, World, Data and Statistics for Health by Country, available at <http://www.worldbank.org/data/databytopic/health.html> (last visited March 19, 2007).+(last+visited+March+19,+2007).>Google Scholar
Id.Google Scholar
Light, D., “The Practice and Ethics of Risk-Rated Health Insurance,” JAMA 267 (1992): 2503–2508; Himmelstein, D. U., Woolhandler, S., and the Writing Committee of the Working Group on Program Design, “A National Health Program for the United States,” New England Journal of Medicine 320 (1989): 102–108; Light, D., “Universal Health Care: Lessons from the British Experience,” American Journal of Public Health 93 (2003): 25–30.CrossRefGoogle Scholar
See Ostrer, et al., supra note 33.Google Scholar
Id.Google Scholar
Id.Google Scholar
See Ad Hoc Committee on Genetic Testing/Insurance Issues, supra note 18.Google Scholar
See Ostrer, et al., supra note 33.Google Scholar